rexlemestrocel-l
Cell therapyexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Mar 1, 2009 (NCT01088191)
Timeline
Indications
Mechanism of action
- Unspecified targetTissue restoration
tissue restoration
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3545318 ↗
Also known as
- msb-car001
- rexlemestrocel
- rexlemestrocel-l
- rexlemestrocel-l
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02412735 | Phase 3 | Mar 1, 2015 | IQVIA, Mesoblast, Inc. |
| NCT01088191 | Phase 1/Phase 2 (Phase 2) | Mar 1, 2009 | Mesoblast, Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Mesoblast, Inc. | For profit | 2 | 2 | 2 | 2009 |
| IQVIA | For profit | 1 | 0 | 1 | 2015 |
2 organizations
Page 1 / 1